Barnes Alane P sold BCRX
May 13, 2026 · Form 4 insider transaction
Barnes Alane P sold 62,500 shares of BioCryst Pharmaceuticals, Inc. at $9.54 per share, a transaction worth $596.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
62,500
Price
$9.54
Total value
$596.3K
InsiderBarnes Alane P
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 13, 2026
Filing dateMay 15, 2026
Shares owned after400,703
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was made pursuant to a plan adopted by the reporting person on August 13, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person.